Moderate Risk | Side Effects Guide

Amitriptyline Side Effects

Side effects of Amitriptyline (ENTRIP) that impact work capacity, driving, and recovery for claims professionals, support workers, and care managers. Also known as ENTRIP, Amitriptyline Lupin, APX-Amitriptyline, Amitriptyline Viatris 10.

Source: PBS, TGA Updated April 2026

Amitriptyline (ENTRIP) is classified as Moderate risk by AllMeds. It is a CNS depressant that can cause drowsiness, impaired coordination, and reduced cognitive function, directly affecting work capacity and return-to-work timelines. It is serotonergic, with risk of serotonin syndrome when combined with other serotonergic medications. For claims professionals, the side effects of Amitriptyline can impact work capacity, driving fitness, and recovery timelines.

Key Takeaways

  • Risk level: Moderate (3 points)
  • CNS depressant: Causes sedation, impairs driving, affects cognitive function
  • Serotonergic: Risk of serotonin syndrome with SSRIs/SNRIs
  • Cardiac risk: QTc prolongation, requires monitoring
  • Claims action: Assess work capacity impact, check for dangerous interactions, review duration against guidelines

Side Effects That Affect Work Capacity

These side effects of Amitriptyline can directly impact a claimant's ability to work, drive, and perform daily activities:

  • Drowsiness and sedation
  • Impaired concentration and cognitive function
  • Slowed reaction time
  • Impaired coordination and balance
  • Drowsiness (especially tricyclic antidepressants)
  • Weight gain

Work capacity certificates should reflect any medication-related restrictions. For safety-sensitive roles (driving, operating machinery, working at heights), these effects may require modified duties or temporary stand-down.

Serious Safety Concerns

These side effects require clinical monitoring and may affect claim management decisions:

  • Risk of serotonin syndrome when combined with other serotonergic drugs
  • Symptoms: agitation, hyperthermia, muscle rigidity, rapid heart rate
  • QTc prolongation (abnormal heart rhythm)
  • Risk of cardiac arrhythmia, especially with other QTc-prolonging drugs

Dependency and Withdrawal

Amitriptyline carries a risk of physical dependence with regular use. This is a common complicating factor in injury claims:

  • Discontinuation syndrome on abrupt cessation

Flags for Claims Professionals

  • CNS depressant effects may delay return to work, particularly in safety-sensitive roles
  • Serotonin syndrome risk if combined with SSRIs, SNRIs, or tramadol
  • QTc prolongation risk requires cardiac monitoring and drug interaction review
  • Assess whether antidepressant prescribing is related to the compensable injury or a pre-existing condition

Check this medication against your full medication list

Run a full risk assessment to check Amitriptyline side effects, interactions, and compliance across the full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.